| Report ID | Date of report | Patient age | Patient gender |
| 75038 | Mar, 3, 2006 | 67 | Female |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Zyprexa | olanzapine |
Alprazolam | alprazolam |
Paxil | paroxetine hydrochloride |
| Name |
Abdominal Pain |
Abdominal Pain Lower |
Alcohol Poisoning |
Alcoholism |
Arteriosclerosis |
Blood Cholesterol Increased |
Blood Creatine Phosphokinase Increased |
Blood Creatine Phosphokinase Mb Increased |
Blood Glucose Increased |
Blood Triglycerides Increased |
Bronchitis |
Cholecystitis Acute |
Chronic Obstructive Pulmonary Disease |
Condition Aggravated |
Convulsion |
Diabetes Mellitus Non-insulin-dependent |
Diabetic Neuropathy |
Drug Level Above Therapeutic |
Drug Screen Positive |
Drug Toxicity |
Dyskinesia |
Fluid Retention |
Glycosylated Haemoglobin Increased |
Hyperlipidaemia |
Hypertension |
Low Density Lipoprotein Increased |
Nausea |
Neuropathy Peripheral |
Opisthotonus |
Overdose |
Parkinson's Disease |
Procedural Pain |
Total Cholesterol/hdl Ratio Decreased |
Treatment Noncompliance |
Tremor |
Vomiting |
Weight Increased |
Results from eHealthMe : 386 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Abdominal Pain | 17 (4.40%) |
Abdominal Pain Lower | 4 (1.04%) |
Alcohol Poisoning | 2 (0.52%) |
Alcoholism | 2 (0.52%) |
Arteriosclerosis | 2 (0.52%) |
Blood Cholesterol Increased | 16 (4.15%) |
Blood Creatine Phosphokinase Increased | 11 (2.85%) |
Blood Creatine Phosphokinase Mb Increased | 1 (0.26%) |
Blood Glucose Increased | 12 (3.11%) |
Blood Triglycerides Increased | 29 (7.51%) |
Bronchitis | 3 (0.78%) |
Cholecystitis Acute | 2 (0.52%) |
Chronic Obstructive Pulmonary Disease | 5 (1.30%) |
Condition Aggravated | 22 (5.70%) |
Convulsion | 5 (1.30%) |
Diabetes Mellitus Non-insulin-dependent | 24 (6.22%) |
Diabetic Neuropathy | 1 (0.26%) |
Drug Level Above Therapeutic | 2 (0.52%) |
Drug Screen Positive | 1 (0.26%) |
Drug Toxicity | 2 (0.52%) |
Dyskinesia | 1 (0.26%) |
Fluid Retention | 3 (0.78%) |
Glycosylated Haemoglobin Increased | 5 (1.30%) |
Hyperlipidaemia | 10 (2.59%) |
Hypertension | 34 (8.81%) |
Low Density Lipoprotein Increased | 4 (1.04%) |
Nausea | 29 (7.51%) |
Neuropathy Peripheral | 16 (4.15%) |
Opisthotonus | 2 (0.52%) |
Overdose | 11 (2.85%) |
Parkinson's Disease | 1 (0.26%) |
Procedural Pain | 1 (0.26%) |
Total Cholesterol/hdl Ratio Decreased | 2 (0.52%) |
Treatment Noncompliance | 15 (3.89%) |
Tremor | 40 (10.36%) |
Vomiting | 36 (9.33%) |
Weight Increased | 50 (12.95%) |
Top 3 (total: 334. Click here to see more) co-used drugs - potential interacting drugs:
| Name | Count (% of total co-drugs) |
Xanax | 360 (5.69%) |
Risperdal | 307 (4.86%) |
Risperidone | 162 (2.56%) |
Death reported: 0
| Name | Count (% of total reports) |
Depression | 156 (40.41%) |
Headache | 91 (23.58%) |
Inappropriate Antidiuretic Hormone Secretion | 83 (21.50%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
